ARS Pharmaceuticals, Inc. (SPRY) Operating cash flow 2020–2025
ARS Pharmaceuticals, Inc. (SPRY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$170.9MFY2025 · since FY2020: -$31.2M → -$170.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$170.9M | -1361.2% |
| FY2024 | $13.5M | +122.9% |
| FY2023 | -$59.3M | -47.9% |
| FY2022 | -$40.1M | -128.2% |
| FY2021 | -$17.6M | +43.7% |
| FY2020 | -$31.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice